Breast Cancer Treatment Trends for 2022
Breast Cancer Treatment Trends for 2022 features Cancer Commons Chief Scientist Emma Shtivelman, PhD, in conversation with former JAMA Editor and Editor at Large for Medscape, Cancer Commons Editor in Chief George Lundberg, MD. During this one-hour event, Dr. Shtivelman discusses the latest significant advancements in treating metastatic breast cancer and answers questions from webinar audience members. This webinar is the inaugural event in the Pat Looney Educational Series for Client Empowerment, a quarterly series focused on providing education and highly-requested information to the cancer-impacted community. The event was held virtually on March 2, 2022. Article with detailed summary of the webinar: https://cancercommons.org/latest-insi... Please connect with us on social media: / cancercommons / cancercommons / cancer-commons / cancercommons
A New Technology for Rapid Therapy Guidance (Webinar Recording)
25 Brutal Truths a Breast Surgeon Learned about Breast Cancer
Testing Matters—Understanding Cancer Biomarker Testing and How It Applies to You
Breast Cancer: Ductal Carcinoma in Situ (DCIS) EXPLAINED
Recurrent Cancer: Unique Treatment Guidance After Cancer Returns (Webinar Recording)
The Real Reason I Stopped Being a Surgeon
10 June | Leadership for Inclusion in Early Childhood: Modelling Cross-Sectoral Collaboration
Use These 5 Food Hacks To Heal The Body & STARVE CANCER I Dr. William Li
Medical breakthroughs and health stories | 60 Minutes Marathon
Restoring Aquatic Ecosystems: Where do Research, Policy, and Practice meet?
Investing in Community Violence Intervention Strategies
You’re Not Alone—Validating the Caregiver Experience
Visualizing Progress in Broadening Participation in Computing: The Value of Context
Americas Launch of Practical Guide for Research Funding Organizations
Stage 2 Breast Cancer Explained: What It Means, How It’s Treated, and What to Expect
Conversations with the JDR and JDR CTR Editors: Inside the Peer Review Process
MI Med Cheryl Martin
Webinar with EUFAMI - Empowering Caregivers, Enhancing Recovery
Pharmacology - Chemotherapy agents (MOA, Alkalating, antimetabolites, topoisomerase, antimitotic)
